Tissue engineering in the vasculature

Anatomical Record

Volumn 297, Issue 1, 2014, Pages 83-97

  Naito, Yuji ^a   Rocco, Kevin ^a   Kurobe, Hirotsugu ^b   Maxfield, Mark ^a   Breuer, Christopher ^b   Shinoka, Toshiharu ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

Stem cell; Tissue engineering; Vasculature

Indexed keywords

ALBUMIN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; FIBRILLIN 1; FIBRINOGEN; FIBRONECTIN; GAMMA INTERFERON; GELATINASE A; GELATINASE B; INTERLEUKIN 13; INTERLEUKIN 4; MICROSOMAL AMINOPEPTIDASE; POLYCAPROLACTONE; POLYGLYCOLIC ACID; POLYHYDOXYALKANOATE; POLYHYDROXYBUTYRATE; POLYLACTIC ACID; SMOOTH MUSCLE ACTIN; TISSUE SCAFFOLD; TROPOELASTIN; UNCLASSIFIED DRUG; UVOMORULIN; VON WILLEBRAND FACTOR;

ARTICLE; BLOOD VESSEL GRAFT; CARDIOVASCULAR SURGERY; CELL MIGRATION; CELL SURFACE; CHILDHOOD DISEASE; CONGENITAL HEART DISEASE; EMBRYONIC STEM CELL; GENE EXPRESSION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LUNG CIRCULATION; MACROPHAGE; MESENCHYMAL STEM CELL; MONOCYTE; MONONUCLEAR CELL; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; STEM CELL; TISSUE ENGINEERED VASCULAR GRAFT; TISSUE ENGINEERING; UPREGULATION; VASCULAR TISSUE; VASCULARIZATION;

STEM CELL; TISSUE ENGINEERING; VASCULATURE;

BLOOD VESSEL PROSTHESIS; HUMANS; REGENERATIVE MEDICINE; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84890437296     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.22838     Document Type: Article

References (65)

1. Abedin M, Tintut Y, Demer LL. 2004. Mesenchymal stem cells and the artery wall. Circ Res 95:671-676.
2. Apostolopoulos V, McKenzie IF. 2001. Role of the mannose receptor in the immune response. Curr Mol Med 1:469-474.
3. Badylak SF, Gilbert TW. 2008. Immune response to biologic scaffold materials. Semin Immunol 20:109-116.
4. Bendeck MP, Zempo N, Clowes AW, Galardy RE, Reidy MA. 1994. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res 75:539-545.
5. Bernacki SH, Wall ME, Loboa EG. 2008. Isolation of human mesenchymal stem cells from bone and adipose tissue. Methods Cell Biol 86:257-278.
6. Brodbeck WG, Anderson JM. 2009. Giant cell formation and function. Curr Opin Hematol 16:53-57.
7. Brodbeck WG, Colton E, Anderson JM. 2003. Effects of adsorbed heat labile serum proteins and fibrinogen on adhesion and apoptosis of monocytes/macrophages on biomaterials. J Mater Sci Mater Med 14:671-675.
8. Daamen WF, Veerkamp JH, van Hest JC, van Kuppevelt TH. 2007. Elastin as a biomaterial for tissue engineering. Biomaterials 28:4378-4398. Epub 2007 Jul 4312.
9. Dahl SL, Kypson AP, Lawson JH, Blum JL, Strader JT, Li Y, Manson RJ, Tente WE, Dibernardo L, Hensley MT, Carter R, Williams TP, Prichard HL, Dey MS, Begelman KG, Niklason LE. 2011. Readily available tissue-engineered vascular grafts. Sci Transl Med 3:68ra69.
10. Davis GE, Senger DR. 2005. Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ Res 97:1093-1107.
11. DeFife KM, Jenney CR, McNally AK, Colton E, Anderson JM. 1997. Interleukin-13 induces human monocyte/macrophage fusion and macrophage mannose receptor expression. J Immunol 158:3385-3390.
12. Elloumi-Hannachi I, Yamato M, Okano T. 2010. Cell sheet engineering: a unique nanotechnology for scaffold-free tissue reconstruction with clinical applications in regenerative medicine. J Intern Med 267:54-70.
13. Esche C, Stellato C, Beck LA. 2005. Chemokines: key players in innate and adaptive immunity. J Invest Dermatol 125:615-628.
14. Godin D, Ivan E, Johnson C, Magid R, Galis ZS. 2000. Remodeling of carotid artery is associated with increased expression of matrix metalloproteinases in mouse blood flow cessation model. Circulation 102:2861-2866.
15. Gogolewski S, Jovanovic M, Perren SM, Dillon JG, Hughes MK. 1993. Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA). J Biomed Mater Res 27:1135-1148.
16. Greiner A, Wendorff JH. 2007. Electrospinning: a fascinating method for the preparation of ultrathin fibers. Angew Chem Int Ed Engl 46:5670-5703.
17. Hanker JS, Giammara BL. 1988. Biomaterials and biomedical devices. Science 242:885-892.
18. Henson PM. 1971. The immunologic release of constituents from neutrophil leukocytes. II. Mechanisms of release during phagocytosis, and adherence to nonphagocytosable surfaces. J Immunol 107:1547-1557.
19. Hibino N, Duncan DR, Nalbandian A, Yi T, Qyang Y, Shinoka T, Breuer CK. 2012a. Evaluation of the use of an induced puripotent stem cell sheet for the construction of tissue-engineered vascular grafts. J Thorac Cardiovasc Surg 143:696-703.
20. Hibino N, Duncan DR, Nalbandian A, Yi T, Qyang Y, Shinoka T, Breuer CK. 2012b. Evaluation of the use of an induced puripotent stem cell sheet for the construction of tissue-engineered vascular grafts. J Thorac Cardiovasc Surg 143:696-703. Epub 2012 Jan 2012.
21. Hibino N, McGillicuddy E, Matsumura G, Ichihara Y, Naito Y, Breuer C, Shinoka T. 2010. Late-term results of tissue-engineered vascular grafts in humans. J Thorac Cardiovasc Surg 139:431-436, 436 e431-e432.
22. Hibino N, Yi T, Duncan DR, Rathore A, Dean E, Naito Y, Dardik A, Kyriakides T, Madri J, Pober JS, Shinoka T, Breuer CK. 2011. A critical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts. FASEB J 24:24.
23. Janatova J. 2000. Activation and control of complement, inflammation, and infection associated with the use of biomedical polymers. ASAIO J 46:S53-S62.
24. Jenney CR, Anderson JM. 2000. Adsorbed serum proteins responsible for surface dependent human macrophage behavior. J Biomed Mater Res 49:435-447.
25. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA, Verfaillie CM. 2002. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49.
26. Koide T, Homma DL, Asada S, Kitagawa K. 2005. Self-complementary peptides for the formation of collagen-like triple helical supramolecules. Bioorg Med Chem Lett 15:5230-5233. Epub 2005 Sep 5226.
27. Kumbar SG, James R, Nukavarapu SP, Laurencin CT. 2008. Electrospun nanofiber scaffolds: engineering soft tissues. Biomed Mater 3:034002.
28. Kuroda Y, Kitada M, Wakao S, Nishikawa K, Tanimura Y, Makinoshima H, Goda M, Akashi H, Inutsuka A, Niwa A, Shigemoto T, Nabeshima Y, Nakahata T, Fujiyoshi Y, Dezawa M. 2010. Unique multipotent cells in adult human mesenchymal cell populations. Proc Natl Acad Sci USA 107:8639-8643. Epub 2010 Apr 8626.
29. Kuwana M, Okazaki Y, Kodama H, Izumi K, Yasuoka H, Ogawa Y, Kawakami Y, Ikeda Y. 2003. Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation. J Leukoc Biol 74:833-845.
30. Langer R, Vacanti JP. 1993. Tissue engineering. Science 260:920-926.
31. Levenberg S, Golub JS, Amit M, Itskovitz-Eldor J, Langer R. 2002. Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 99:4391-4396.
32. Lin H, Shabbir A, Molnar M, Yang J, Marion S, Canty JM, Jr., Lee T. 2008. Adenoviral expression of vascular endothelial growth factor splice variants differentially regulate bone marrow-derived mesenchymal stem cells. J Cell Physiol 216:458-468.
33. Madden RL, Lipkowitz GS, Browne BJ, Kurbanov A. 2004. Experience with cryopreserved cadaveric femoral vein allografts used for hemodialysis access. Ann Vasc Surg 18:453-458.
34. Matsumura G, Ishihara Y, Miyagawa-Tomita S, Ikada Y, Matsuda S, Kurosawa H, Shin'oka T. 2006. Evaluation of tissue-engineered vascular autografts. Tissue Eng 12:3075-3083.
35. Matsumura G, Miyagawa-Tomita S, Shin'oka T, Ikada Y, Kurosawa H. 2003. First evidence that bone marrow cells contribute to the construction of tissue-engineered vascular autografts in vivo. Circulation 108:1729-1734.
36. McCloskey KE, Gilroy ME, Nerem RM. 2005. Use of embryonic stem cell-derived endothelial cells as a cell source to generate vessel structures in vitro. Tissue Eng 11:497-505.
37. Mecham RP, Davis EC. 1994. Extracellular matrix assembly and structure. San Diego, CA: Academic Press.
38. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. 2000. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 164:6166-6173.
39. Mirza A, Hyvelin JM, Rochefort GY, Lermusiaux P, Antier D, Awede B, Bonnet P, Domenech J, Eder V. 2008. Undifferentiated mesenchymal stem cells seeded on a vascular prosthesis contribute to the restoration of a physiologic vascular wall. J Vasc Surg 47:1313-1321.
40. Naito Y, Imai Y, Shin'oka T, Kashiwagi J, Aoki M, Watanabe M, Matsumura G, Kosaka Y, Konuma T, Hibino N, Murata A, Miyake T, Kurosawa H. 2003. Successful clinical application of tissue-engineered graft for extracardiac Fontan operation. J Thorac Cardiovasc Surg 125:419-420.
41. Naito Y, Shinoka T, Duncan D, Hibino N, Solomon D, Cleary M, Rathore A, Fein C, Church S, Breuer C. 2011. Vascular tissue engineering: towards the next generation vascular grafts. Adv Drug Deliv Rev 63:312-323.
42. Naito Y, Williams-Fritze M, Duncan DR, Church SN, Hibino N, Madri JA, Humphrey JD, Shinoka T, Breuer CK. 2012. Characterization of the natural history of extracellular matrix production in tissue-engineered vascular grafts during neovessel formation. Cells Tissues Organs 195:60-72. doi: 10.1159/000331405. Epub 000332011 Oct 000331412.
43. O'Cearbhaill ED, Murphy M, Barry F, McHugh PE, Barron V. 2010. Behavior of human mesenchymal stem cells in fibrin-based vascular tissue engineering constructs. Ann Biomed Eng 38:649-657.
44. Okano T, Yamada N, Okuhara M, Sakai H, Sakurai Y. 1995. Mechanism of cell detachment from temperature-modulated, hydrophilic-hydrophobic polymer surfaces. Biomaterials 16:297-303.
45. Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. 2008. Generation of mouse induced pluripotent stem cells without viral vectors. Science 322:949-953.
46. Pachence JM, Kohn J. 2000. Biodegradable polymers. In: Lanza RT, Langer R, Vacanti JP, editors. Principle of tissue engineering, 2nd ed. San Diego, CA: Academic Press. p 263-277.
47. Paramonov SE, Jun HW, Hartgerink JD. 2006. Self-assembly of peptide-amphiphile nanofibers: the roles of hydrogen bonding and amphiphilic packing. J Am Chem Soc 128:7291-7298.
48. Piterina AV, Cloonan AJ, Meaney CL, Davis LM, Callanan A, Walsh MT, McGloughlin TM. 2009. ECM-based materials in cardiovascular applications: inherent healing potential and augmentation of native regenerative processes. Int J Mol Sci 10:4375-4417.
49. Pitt CG, Marks TA, Schindler A. 1981. Biodegradable drug delivery systems based on aliphatic polyesters: application to contraceptives and narcotic antagonists. NIDA Res Monogr 28:232-253.
50. Roh JD, Sawh-Martinez R, Brennan MP, Jay SM, Devine L, Rao DA, Yi T, Mirensky TL, Nalbandian A, Udelsman B, Hibino N, Shinoka T, Saltzman WM, Snyder E, Kyriakides TR, Pober JS, Breuer CK. 2010. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling. Proc Natl Acad Sci USA 107:4669-4674.
51. Schuldiner M, Yanuka O, Itskovitz-Eldor J, Melton DA, Benvenisty N. 2000. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 97:11307-11312.
52. Shen G, Tsung HC, Wu CF, Liu XY, Wang XY, Liu W, Cui L, Cao YL. 2003. Tissue engineering of blood vessels with endothelial cells differentiated from mouse embryonic stem cells. Cell Res 13:335-341.
53. Shin'oka T, Imai Y, Ikada Y. 2001. Transplantation of a tissue-engineered pulmonary artery. N Engl J Med 344:532-533.
54. Shin'oka T, Matsumura G, Hibino N, Naito Y, Watanabe M, Konuma T, Sakamoto T, Nagatsu M, Kurosawa H. 2005. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg 129:1330-1338.
55. Shinoka T, Shum-Tim D, Ma PX, Tanel RE, Isogai N, Langer R, Vacanti JP, Mayer JE, Jr. 1998. Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg 115:536-545; discussion 545-536.
56. Stegemann JP, Kaszuba SN, Rowe SL. 2007. Review: advances in vascular tissue engineering using protein-based biomaterials. Tissue Eng 13:2601-2613.
57. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872.
58. Tang L, Ugarova TP, Plow EF, Eaton JW. 1996. Molecular determinants of acute inflammatory responses to biomaterials. J Clin Invest 97:1329-1334.
59. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. 1998. Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147.
60. Walles T, Gorler H, Puschmann C, Mertsching H. 2004. Functional neointima characterization of vascular prostheses in human. Ann Thorac Surg 77:864-868.
61. Wang JF, Wang LJ, Wu YF, Xiang Y, Xie CG, Jia BB, Harrington J, McNiece IK. 2004. Mesenchymal stem/progenitor cells in human umbilical cord blood as support for ex vivo expansion of CD34(+) hematopoietic stem cells and for chondrogenic differentiation. Haematologica 89:837-844.
62. Wang R, Clark R, Bautch VL. 1992. Embryonic stem cell-derived cystic embryoid bodies form vascular channels: an in vitro model of blood vessel development. Development 114:303-316.
63. Watanabe M, Shin'oka T, Tohyama S, Hibino N, Konuma T, Matsumura G, Kosaka Y, Ishida T, Imai Y, Yamakawa M, Ikada Y, Morita S. 2001. Tissue-engineered vascular autograft: inferior vena cava replacement in a dog model. Tissue Eng 7:429-439.
64. Yamashita J, Itoh H, Hirashima M, Ogawa M, Nishikawa S, Yurugi T, Naito M, Nakao K. 2000. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408:92-96.
65. Zhang L, Zhou J, Lu Q, Wei Y, Hu S. 2008. A novel small-diameter vascular graft: in vivo behavior of biodegradable three-layered tubular scaffolds. Biotechnol Bioeng 99:1007-1015.